We use cookies to give you the best online experience. By using our website you agree to our use of cookies in accordance with our cookie policy. Learn more here.Close Me
Ireland, in common with many other jurisdictions, has
experienced a significant level of debate regarding generic drugs
and the use of "reference pricing" by state-sponsored
medical services providers and Community Drugs Schemes (CDS).
Government proposals on this topic were recently clarified in
the Health (Pricing and Supply of Medicines) Bill, published on 16
July 2012.
In a year where the Health Service Executive has overspent by
€280 million, the Government sees the introduction of this
legislation as a means of promoting competition between suppliers
of interchangeable medicines and achieving greater reductions in
the medicines bill for the State.
The objective of the Bill is to:
establish a list of groups of interchangeable medicinal
products, which may be substituted for each other;
alter the duties of prescribers and dispensers of medicines to
facilitate the operation of the reference pricing system; and
establish a list of medicines and medical and surgical
appliances that may be supplied to patients under the General
Medical Services Scheme (GMS) and CDS, and create mechanisms for
setting the prices of those reimbursable items.
As the Irish Parliament is in summer recess until 18 September
2012, there will be no legislative progress on the Bill until after
that date. It is next due to go before the Irish Senate for
debate. We expect that the Bill will be subject to
significant lobbying and debate and propose to track and update you
on any significant changes, as the Bill progresses through the
legislative process.
For a more detailed overview of the Bill, please click
here.
The full text of the Bill can also be viewed here.
The content of this article is intended to provide a general
guide to the subject matter. Specialist advice should be sought
about your specific circumstances.
To print this article, all you need is to be registered on Mondaq.com.
Click to Login as an existing user or Register so you can print this article.
Under the NHS reforms, CCGs now have responsibility for commissioning healthcare services to meet the reasonable needs of the persons for whom they are responsible.
The main purpose of this brief information note is to indicate the regulations of healthcare services and health insurances available for foreigners in Turkey
Leaders from some of the South West’s biggest and most successful industries have come together to draw a road map to the region becoming Britain’s agri-food sector ‘centre of excellence’.
Parallel to the harmonisation process of Turkish legislation with European Union law, the legal environment regarding veterinary products is also evolving in Turkey.
There have been specific rules governing the promotion of medicinal products in Turkey since the beginning of the 90’s.
Some comments from our readers… “The articles are extremely timely and highly applicable” “I often find critical information not available elsewhere” “As in-house counsel, Mondaq’s service is of great value”
